federal_register: 2016-28971
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2016-28971 | Physiologically Based Pharmacokinetic Analyses-Format and Content; Draft Guidance for Industry; Availability | Notice | The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled "Physiologically Based Pharmacokinetic Analyses--Format and Content." This guidance recommends to drug sponsors the format and content for submitting physiologically based pharmacokinetic (PBPK) analyses to FDA to enable efficient and consistent review. | 2016-12-02 | 2016 | 12 | https://www.federalregister.gov/documents/2016/12/02/2016-28971/physiologically-based-pharmacokinetic-analyses-format-and-content-draft-guidance-for-industry | https://www.govinfo.gov/content/pkg/FR-2016-12-02/pdf/2016-28971.pdf | Health and Human Services Department; Food and Drug Administration | 221,199 | The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled "Physiologically Based Pharmacokinetic Analyses--Format and Content." This guidance recommends to drug sponsors the format and... |